These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 18190323

  • 61. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.
    Lai CH, Wong WW, Chin C, Huang CK, Lin HH, Chen WF, Yu KW, Liu CY.
    Clin Microbiol Infect; 2006 Oct; 12(10):986-91. PubMed ID: 16961635
    [Abstract] [Full Text] [Related]

  • 62. Stenotrophomonas maltophilia keratitis and scleritis.
    Chen YF, Chung PC, Hsiao CH.
    Chang Gung Med J; 2005 Mar; 28(3):142-50. PubMed ID: 15945320
    [Abstract] [Full Text] [Related]

  • 63. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY.
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [Abstract] [Full Text] [Related]

  • 64. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM.
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [Abstract] [Full Text] [Related]

  • 65. Stenotrophomonas maltophilia and Mycobacterium chelonae coinfection of the extraocular scleral buckle explant.
    Liu DT, Lee VY, Chi-Lai L, Lam DS.
    Ocul Immunol Inflamm; 2007 Oct; 15(6):441-2. PubMed ID: 18085488
    [Abstract] [Full Text] [Related]

  • 66. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
    Rolston KV.
    Clin Infect Dis; 2005 Apr 01; 40 Suppl 4():S246-52. PubMed ID: 15768330
    [Abstract] [Full Text] [Related]

  • 67. Stenotrophomonas maltophilia keratitis treated with trimethoprim-sulfamethoxazole.
    Díez-Álvarez L, Lumbreras-Fernández B, García-Pérez JL.
    Arch Soc Esp Oftalmol; 2015 Nov 01; 90(11):539-41. PubMed ID: 26008926
    [Abstract] [Full Text] [Related]

  • 68. Role of Stenotrophomonas maltophilia in hospital-acquired infection.
    Looney WJ.
    Br J Biomed Sci; 2005 Nov 01; 62(3):145-54; quiz 1 p following 154. PubMed ID: 16196464
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
    Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A.
    Eur J Clin Microbiol Infect Dis; 2007 Jan 01; 26(1):13-20. PubMed ID: 17200840
    [Abstract] [Full Text] [Related]

  • 71. The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004.
    Jumaa PA, Sonnevend A, Pàl T, El Hag M, Amith R, Trad O.
    Ann Clin Microbiol Antimicrob; 2006 Dec 28; 5():32. PubMed ID: 17194302
    [Abstract] [Full Text] [Related]

  • 72. Emerging and unusual gram-negative infections in cystic fibrosis.
    Davies JC, Rubin BK.
    Semin Respir Crit Care Med; 2007 Jun 28; 28(3):312-21. PubMed ID: 17562501
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review.
    Nyc O, Matejková J.
    Folia Microbiol (Praha); 2010 May 28; 55(3):286-94. PubMed ID: 20526844
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
    Zelenitsky SA, Iacovides H, Ariano RE, Harding GK.
    Diagn Microbiol Infect Dis; 2005 Jan 28; 51(1):39-43. PubMed ID: 15629227
    [Abstract] [Full Text] [Related]

  • 78. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
    Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E, Ratjen F.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):635-40. PubMed ID: 20889901
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge.
    Gil-Gil T, Martínez JL, Blanco P.
    Expert Rev Anti Infect Ther; 2020 Apr 01; 18(4):335-347. PubMed ID: 32052662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.